Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Sharif‐Yakan, C. Nienaber (2015)
Pharmacological Management of Cardiac Syndrome Y: A Focused Review, 3
G. Fragasso, S. Chierchia, F. Arioli, O. Carandente, S. Gerosa, M. Carlino, A. Palloshi, L. Gianolli, G. Calori, F. Fazio, A. Margonato (2009)
Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: long-term clinical and functional prognosis.International journal of cardiology, 137 2
M. Anwar, Y. Omran (2014)
Coronary slow flow: Benign or ominous?Anatolian Journal of Cardiology, 16
J. Herrmann, J. Kaski, A. Lerman (2012)
Coronary microvascular dysfunction in the clinical setting: from mystery to reality.European heart journal, 33 22
K. Sadamatsu, H. Tashiro, Keiki Yoshida, Tomoki Shikada, K. Iwamoto, Kunio Morishige, Y. Yoshidomi, T. Tokunou, Haruki Tanaka (2010)
Acute Effects of Isosorbide Dinitrate and Nicorandil on the Coronary Slow Flow PhenomenonAmerican Journal of Cardiovascular Drugs, 10
Am J Cardiovasc Drugs (2018) 18:73–74 https://doi.org/10.1007/s40256-017-0241-4 RESEARCH LETTER Long-Term Follow-up of Patients with Coronary Slow Flow Phenomenon 1,2 1 2 • • Kenji Sadamatsu Yasuaki Koga Hideki Tashiro Published online: 28 June 2017 Springer International Publishing AG 2017 The coronary slow flow phenomenon (CSFP) is an angio- flow was improved after the administration of isosorbide graphic finding characterized by the delayed progression of dinitrate or nicorandil and delayed after the subsequent contrast medium in an epicardial coronary artery without contrast injection in all patients. The CSFP was observed stenosis during routine coronary angiography. In daily in the left anterior descending artery, the right coronary practice at catheterization laboratories, coronary slow flow artery, and the circumflex artery in five, three, and two is not a rare finding; however, CSFP has received little patients, respectively. The median follow-up period was attention, and its natural history is still unclear. We 2511 (range 1703–3303) days, and calcium channel therefore conducted a long-term follow-up study of the blockers were administered in five patients, while coro- patients with CSFP from our previous study [1]. nary vasodilators were stopped by home doctors in the We prospectively collected 11 patients with CSFP other two patients. There
American Journal of Cardiovascular Drugs – Springer Journals
Published: Jun 28, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.